A West Texas Doctor claims he’s found the “silver bullet” for COVID-19, but the treatment is not currently approved by the FDA, KOSA 7 Texas reported.
Budesonide is used to help prevent the symptoms of asthma. When used regularly every day, inhaled budesonide decreases the number and severity of asthma attacks. However, it will not relieve an asthma attack that has already started. Budesonide is a corticosteroid or steroid (cortisone-like medicine). It works by preventing inflammation (swelling) in the lungs, which makes the asthma attack less severe. Inhaled budesonide may be used with other asthma medicines such as bronchodilators, which are also used to open up narrowed breathing passages in the lungs.
Dr. Richard Bartlett works at various clinics around West Texas, and says he’s found a successful treatment for the coronavirus.
“The treatment plan is inhaled, generic budesonide,” Bartlett said. “Using some generic antibiotics to protect from a secondary bacterial infection. Using zinc, which interferes with virus replication. It’s common sense. It’s intuitive.”
Budesonide is a steroid, that can be inhaled directly to the lungs using a nebulizer.
This story first appeared on the radar in late May , since than DR Bartlett has continued to treat and basically cure as he claims covid symptoms from patients. . A local hospital in Texas, does not agree with this treatment, creating a local stir, however many of his patients have come to his defense and claim Budesonide otherwise known as the brand name Pulmicort is the silver bullet for coronavirus.
Dr Bartlett might be on to something, but is not the only one using asthma medications to treat coronavirus patients.
Researchers from Queensland University of Technology and Oxford University are working in collaboration to begin human clinical trials of inhaled corticosteroids, commonly used for asthma patients, on patients with COVID-19. The researchers believe that this could be useful for patients with the novel coronavirus infection.
News, Medical Life Sciences reported: Lead researcher on this team Dan Nicolau, an associate professor at QUT, explained that the asthmatics and those with chronic lung disease and chronic obstructive pulmonary disease (COPD) were on regular inhaler therapy with corticosteroids, were found to have a lesser risk of severe illness in the early phase of the pandemic. He said that this was paradoxical because those with long term lung disease were initially considered to be at a higher risk of a respiratory viral infection such as SARS-CoV-2. He said in his statement, “This seemed paradoxical because COVID-19 affects the lungs – and these patients have lung problems – so they should be more at risk of severe disease from the virus.”
Here is the original report from local Texas Media News West 9 in May and the 2 follow up news stories on this issue, including a hospital disagreeing with Dr. Bartlett and another report from his actual patients defending his treatment. These are interesting developments and we could be hearing a lot more about this treatment, which does not have FDA approval. It is amazing that this has not drawn major media attention and has flown under the radar since late May
This story reappeared in the news yesterday, when the same news network spoke to a local hospital that belives there are not enough studies to prove that budesonide works, they followed up again with a third report on Thursday interviewing patients who are defending Dr Bartlett’s treatment.
Here is the latest report in defense of Bartlett’s discoveries. Testimonies that this treatment saved their lives